Welcome to our dedicated page for Afya SEC filings (Ticker: AFYA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Afya Limited (AFYA) is a foreign private issuer that reports to the U.S. Securities and Exchange Commission primarily through Form 20‑F and Form 6‑K. This SEC filings page centralizes access to those documents, which provide detailed information on the company’s operations as a medical education group and medical practice solutions provider in Brazil.
Afya’s Form 20‑F annual report contains audited financial statements and extensive narrative disclosures on its three reportable segments: Undergraduate, Continuing Education and Medical Practice Solutions. Investors can review segment definitions, revenue composition, key operational metrics and risk factors related to its physician‑centric ecosystem and Brazilian regulatory environment.
Throughout the year, Afya files multiple Form 6‑K reports. These include unaudited interim condensed consolidated financial statements, press releases announcing quarterly and half‑year financial results, and disclosures on specific corporate events. Examples documented in recent 6‑Ks include new share repurchase programs for Class A common shares, issuance of commercial notes by Afya Participações S.A., repayment of debentures, repurchase and cancellation of Series A perpetual convertible preferred shares, changes to the board of directors, results of the annual general meeting and the engagement of a new independent registered public accounting firm.
For investors analyzing AFYA, these filings are key sources for understanding revenue trends, adjusted EBITDA, net income, capital structure decisions and governance developments. They also provide context on Afya’s medical school seat authorizations and other regulatory milestones in Brazil’s higher education sector.
On Stock Titan, Afya’s SEC filings are updated in line with EDGAR submissions and can be paired with AI‑powered summaries that explain the main points of lengthy documents. Users can quickly identify which filings relate to financial results, capital markets transactions, governance changes or other material events, and then drill down into the full text when deeper analysis is required.
Afya Ltd executive Anibal Jose Grifo de Sousa, V.P. Legal, Compliance & Government Relations, exercised stock options covering 19,000 Class A common shares at $11.83 per share. This option exercise converted derivative holdings into common stock and did not involve any open-market sale.
Following the transaction, he directly owns 50,000 Class A common shares. The related stock option for 19,000 shares, originally exercisable beginning on May 1, 2025 and expiring on May 1, 2028, now shows zero derivative shares remaining in this award.
Afya Ltd Vice President Junior Lelio de Souza exercised stock options to acquire 66,000 Class A common shares on April 22, 2026. The options had an exercise price of $11.83 per share. After these transactions, he directly holds 66,000 Class A common shares and 6,000 stock options.
Afya Ltd Controller Welder Ferreira Santos reported an open-market sale of 3,325 Class A common shares. The shares were sold at an average price of $15.90 per share. After this transaction, the insider directly holds 35,000 Class A common shares, indicating the sale represents a relatively small portion of their overall position.
Afya Ltd executive Anibal Jose Grifo de Sousa, VP Legal, Compliance and Government Relations, reported open-market sales of Class A common shares. On April 13, 2026, he sold a total of 14,000 shares in three transactions priced between $15.35 and $15.50 per share. Following these sales, he directly holds 31,000 Class A common shares.
Afya Ltd Vice President Junior Lelio de Souza reported an open-market sale of Class A common shares. On April 9, 2026, he sold 16,279 Class A Common Shares at a price of $14.53 per share, leaving him with 0 shares of this security held directly after the transaction.
Afya Ltd Chief Financial Officer sells shares in open-market trade. CFO Luis Andre Carpintero Blanco sold 10,000 Class A common shares of Afya Ltd in an open-market transaction at $15.20 per share. After this sale, he directly holds 51,103 Class A common shares.
Afya Ltd Vice President Junior Lelio de Souza sold Class A shares in an open-market trade. He sold 26,753 Class A common shares at $14.95 per share and now directly holds 16,279 shares. This was a straightforward sale of existing stock, with no derivatives reported.
Afya Ltd executive Anibal Jose Grifo de Sousa, VP Legal, Compliance and Government Relations, conducted an open-market sale of 5,000 Class A Common Shares on April 7, 2026 at $15.20 per share. After this transaction, he continues to hold 45,000 Class A Common Shares directly, indicating he retains a substantial personal stake in the company despite trimming his position.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of Class A common shares. On April 2, he sold 20,900 shares at $14.94 per share, and on April 6, he sold 770 shares at $14.91 per share.
After these sales, he holds 108,448 Class A shares directly and an additional 200,000 Class A shares indirectly through GIBBOAT OVERSEAS LTD, which is solely owned and controlled by him. The 21,670 shares sold represent a small portion of his overall position.
Afya Ltd Chief Executive Officer Gibbon Virgilio Deloy Capobianco reported open-market sales of 21,820 Class A Common Shares of Afya Ltd over two days. He sold 19,500 shares on April 1, 2026 at $14.98 per share and 2,320 shares on March 31, 2026 at $14.92 per share.
Following these transactions, he holds 130,118 Class A Common Shares directly. He also has an indirect holding of 200,000 Class A Common Shares through GIBBOAT OVERSEAS LTD, which the footnote states is solely owned and controlled by him.